Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate

British Journal of Cancer

Volumn 80, Issue 10, 1999, Pages 1617-1622

  Wang, L S ^a,b   Chow, K C ^a   Wu, C W ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Interleukin 6; Oesophageal carcinoma; Sodium butyrate; Up regulation

Indexed keywords

BUTYRIC ACID; GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MESSENGER RNA;

ADULT; AGED; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

BASE SEQUENCE; BUTYRIC ACID; CARCINOMA, SQUAMOUS CELL; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INTERLEUKIN-6; MALE; RECEPTORS, INTERLEUKIN-6; RNA, MESSENGER; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0032990516     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690571     Document Type: Article

References (50)

1. Baba M, Hasegawa H, Nakayabu M, Shimizu N, Suzuki S, Kamada N and Tani K (1995) Establishment and characteristics of a gastric cancer cell line (HuGC-OOHIRA) producing high levels of G-CSF, GM-CSF, and IL-6; the presence of autocrine growth control by G-CSF. Am J Hematol 49; 207-215
2. Blay JY, Negrier S, Combaret V, Altali S, Goillot E, Merrouche Y, Mercatello A, Ravault A, Tourani JM and Moskuvtchenko JF (1992) Serum level of interleukin 6 as a prognostic factor in metastatic renal cell carcinoma. Cancer Res 52: 3317-3322
3. Castell JV, Gomez Lechon MJ, David M, Horano T, Kishimoto T and Heinrich PC (1990) Acute phase responses of human hepatocytes: regulation of acute phase protein synthesis by IL 6. Hepatology 12: 1179-1186
4. Chiu CF. Chow KC, Lin FM, Lin CK, Liu SM and Chen KY (1997) Expression of DNA topoisomerase IIα and multidrug resistance p-glycoprotein in acute leukemia. Chin Med J (Taipei) 60: 184-190
5. Chow KC and Chen KY (1995) The role of Epstein-Barr virus infection and the immunocompetence of patients with nasopharyngeal cancers. Therapeutic Radiol Oncol 2: 243-260
6. Chow KC, Nacilla JQ. Witzig TE, and Li CY (1992) Is persistent polyclonal B lymphocytosis caused by Epstein Barr virus? A study with polymerase chain reaction and in situ hybridization. Am J Hematol 41: 270-275
7. Chow, KC, Zhang JH, Chou SL, Tseng WS and Chen KY (1997) The application of virus in the diagnosis and therapy of tumor, Therapeutic Radiol Oncol 4: 155-178
8. Eustace D, Han X, Gooding R, Rowbottom A, Riches P and Heyderman F. (1993) Interleukin 6 (IL-6) functions as an autocrine growth factor in cervical carcinoma in vitro. Gyneccol Oncol 50: 151-159
9. Gauldie J, Richards C, Marnish D, Lansdorp P and Baumann H (1987) Interferon β 2/BSF2 shares identity with monocyte derived hepatocyte stimulating factor and regulates the major acute phase protein in liver cells. Proc Natl Acad Sci USA 84: 7251-7255
10. Inoue M, Minami M, Fujii Y, Matsuda H, Shirakura R and Kido T (1997) Granulocyte colony-stimulating factor and interleukin-6 producing lung cancer cell line, LCAM. J Surg Oncol 64: 347-350
11. Kabir S and Daar GA (1995) Serum levels of interleukin-1, interleukin-6 and tumour necrosis factor-alpha in patients with gastric carcinoma. Cancer Lett 95: 207-212
12. Kaplan EL and Meier P (1958) Nonparametric estimation from incomplete observations. Am Stat Assoc J 53: 457-481
13. Katlic MR, Wilkins EW and Grillo HC (1990) Three decades of treatment of ocsophageal squamous carcinoma at the Massachusetts General Hospital. J Thorac Cardiovasc Surg 99: 929-938
14. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O and Tanaka H (1988) Autocrine generation and requirement of BSF-2/IL-6 for human multiple myeloma. Nature 332: 83-85
15. Kishimoto T (1990) The biology of interleukin 6. Blood 74: 1-10
16. Lee JD, Sievers TM, Skotzko M, Chandler CF, Morton DL, McBride WH and Economou JS (1992) Interleukin 6 production by human melanoma cell lines. Lymphokine Cytokine Res 11: 161-166
17. Liu CC, Fahn HJ, Li WY, Wu YC, Huang MH and Wang LS (1998) Lymph node metastasis in squamous cell carcinoma of the intrathoracic esophagus. Chin Med J (Taopei) 61: 77-84
18. Miki S, Iwano M, Miki Y, Yamamoto M, Tang B, Yokokawa K, Sonoda T, Hirano T and Kishimoto T (1989) Interleukin 6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 250: 607-610
19. Ni K and O'Neill HC (1992) Proliferation of the BCL1 B cell lymphoma induced by IL-4 and IL-5 is dependent on IL-6 and GM-CSF. Immunol Cell Biol 70: 315-321
20. Obata NH, Tamakoshi K, Shibata K, Kikkawa F and Tomoda Y (1997) Effects of interleukin-6 on in vitro cell altachment, migration and invasion of human ovarian carcinoma. Anticancer Res 17: 337-342
21. Oka M, Yamamoto K, Takahashi M, Hakozaki M, Abe T, Iizuka N, Hazama S, Hirazawa K, Hayashi H, Tangoku A, Hirose K, Ishihara T and Suzuki T (1996) Relationship between serum levels of interleukin 6, various disease parameters, and malnutrition in patients with oesophageal carcinoma. Cancer Res 56: 2776-2780
22. 2/E in the log-rank test for survival data or incidence data. Biometrics 29: 579-534
23. Ray A, Tatler SB, May LT and Sehgal PB (1988) Activation of the human '3,-interferon/hepatocyte-stimulating factor/interleukin 6′ promoter by cytokines, viruses, and second messenger agonists. Proc Natl Acad Sci USA 85: 6701-6705
24. Reichner JS, Mulligan JA, Palla ME, Hixson DC, Albina JE and Bland K (1996) Interleukin-6 production by rat hepatocellular carcinoma cells is associated with metastatic potential but not with tumorigenicity, Arch Surg 131: 360-365
25. Scambia G, Testa U, Benedetti Panici P, Foti E, Martucci R, Gadducci A, Perillo A, Facchini V, Peschle C and Mancuso S (1995) Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer. Br J Cancer 71; 354-356
26. Seymour JF, Talpaz M, Hagemeister FB, Cabanillas F and Kurzrock R (1997) Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's disease. Am J Med 102: 21-28
27. Stein TP, Koemer B, Schluter MD, Leskiw MJ, Gaprindachvilli T, Richards EW, Cope FO and Condolucci D (1997) Weight loss, the gut and the inflammatory response in Aids patients, Cytokine 9: 143-147
28. Strassmann G, Fong M, Kenney JS and Jacob CO (1992a) Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 89: 1681-1684
29. Strassmann G, Jacob CO, Evans R, Beall D and Fong M (1992b) Mechanism of experimental cancer cachexia. Interaction between mononuclear phagocytes and colon-26 carcinoma and its relevance to IL-6-mediated cancer cachexia J Immunol 148: 3674-3678
30. Stephanou A, Knight RA, Annicchrarico-Petruzzelli M, Finazzi-Agro A, Lightmann SL and Melino G (1992) Interleukin-1 heta and interleukin-6 mRNA are expressed in human glioblastoma and neurohlastoma cells respectively. Funct Neurol 7: 129-133
31. Tabibzadeh SS, Pouhouridis D, May LT and Sehgal PB (1989) Interleukin 6 immunoactivity in human tumors, Am J Pathol 135: 427-433
32. Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T, Hirano T and Kishimoto T (1989) Interleukin-6 triggers the association of its receptor with a possible signal transducer. gpl30. Cell 58: 573-581
33. Takeuchi E, Ito M, Mori M, Yamaguchi T, Nakagawa M, Yokota S, Nishikawa H, Sakuma-Mochizuki J, Hayashi S and Ogura T (1996) Lung cancer producing interleukin-6. Intern Med 35: 212-214
34. Takizuwa H, Ohtoshi T, Ohta K, Yamashita N, Hirohata S, Hirai K, Hiramatsu K and Ito K (1993) Growth inhibition ot human lung cancer cell lines by interleukin 6 in vitro: a possible role in tumor growth via an autocrine mechanism. Cancer Res 53: 4175-4181
35. Tamura S, Fujimoto-Ouchi K, Mori K, Endo M, Matsumoto T, Eden H, Tanaka Y, Ishitsuka H, Tokita H and Yamaguchi K (1995) Involvement of human interleukin 6 in experimental cachexia induced by a human uterine carcinoma xenograft. Clin Cancer Res 1: 1353-1358
36. Tanner J and Tosato G (1991) Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice. J Clin Invest 88: 239-247.
37. VanMeir E, Sawamura Y, Diserens AC, Hamou MF and de Tribolet N (1990) Human glioblastoma cells release interleukin 6 in vitro and in vivo. Cancer Res 50: 6683-6688
38. Walker PR, Saas P and Dietrich PV (1997) Role of Fas ligand (CD951.) in immune ESCCape. J Immunol 158: 4521-4524
39. Wang GG, Witek-Giannotti J, Hewick RM, Clark SC and Ogawa M (1988) Interleukin 6: identification as a hematopoietic colony-stimulating factor. Behring Inst Mitt 83: 40-47
40. Wang LS, Huang MH, Huang BS and Chien KY (1992) Gastric substitution for resectable carcinoma of the esophagus. An analysis of 368 cases. Ann Thorac Surg 53: 289-294
41. Wang LS, Chi KH, Hu MH, Fahn HJ and Huang MH (1996) Management for patients with advanced T4 epidermoid carcinoma of the esophagus. J Surg Oncol 62: 22-29
42. Wang LS, Lin HY, Chang CJ, Fahn HJ, Huang MH and Lin CF (1998) Effects of en bloc esophagectomy on nutritional and immune status in patients with esophageal carcinoma. J Surg Oncology 67: 90-98
43. Watson JM, Sensintaffar JL, Berck JS and Martinez Maza O (1990) Constitutive production of interleukin 6 in viro: a possible role in tumor growth via an autocrine mechanism. Cancer Res 50: 6959-6965
44. Wojciechowska-Lacka A, Matecka-Nowak M, Adamiak E, Lacki JK and Cerkaska-Gluszak B (1996) Serum levels of interleukin-10 and interleukin-6 in patients with lung cancer. Neoplasma 43: 155-158
45. Wu CW, Wang SR, Chao MF, Wu TC, Lui WY, P'eng FK and Chi CW (1996) Serum interleukin-6 levels reflect disease status of gastric cancer. Am J Gastroenterol 91: 1417-1422
46. Wu YK, Chen PT, Fang J and Lin SS (1980) Surgical treatment of oesophageal carcinoma. Am J Surg 139: 805-809
47. Yamasaki K, Taga T, Hirata Y, Yawata H, Kawanishi Y, Seed B, Taniguchi T, Hirano T amd Kishimoto T (1988) Cloning and expression of the human interleukin-6 (BFS-2/IFNB2) receptor. Science 241: 825-828
48. Yamashita S, Ogawa M, Abe T, Yamashita J, Sakamoto K, Niwa H and Yamamura K (1994) Group II phospholipase A2 in invasive gastric cancer cell line is induced by interleukin 6. Biochem Biophys Res Commun 198: 878-884
49. Yanagawa H, Sone S, Takahashi Y, Haku T, Yano S, Shinohara T and Ogura T (1995) Serum levels of interleukin 6 in patients with lung cancer. Br J Cancer 71: 1095-1098
50. 2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. J Biol Chem 263: 6177-6182